Literature DB >> 10474853

Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy.

M Kurihara1, H Shimizu, K Tsuboi, K Kobayashi, M Murakami, K Eguchi, K Shimozuma.   

Abstract

The Japanese Quality of Life Research Group has developed a general questionnaire suitable for assessing the Quality of Life (QOL) in patients undergoing chemotherapy. The questionnaire covers four major categories: (1) daily activities, (2) physical condition, (3) social activities, and (4) mental and psychological status. The State-Trait Anxiety Inventory (STAI), Self-Rating Depression Scale (SDS), and Performance Status (PS) were used as external measures of quality of life and for the validation of our tool. On the basis of two basic surveys and two studies we selected 22 questions from a larger set of items. Validity and reliability were verified for the final 22-question form. This questionnaire, named the QOL Questionnaire for Cancer Patients Treated with Anticancer Drugs (QOL-ACD), can be used to detect changes in QOL over time. Its use as an additional outcome measure in Phase III chemotherapy trials should be encouraged.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10474853     DOI: 10.1002/(SICI)1099-1611(199907/08)8:4<355::AID-PON401>3.0.CO;2-I

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  32 in total

1.  Analysis of incomplete quality of life data in advanced stage cancer: a practical application of multiple imputation.

Authors:  Satoshi Morita; Kunihiko Kobayashi; Kenji Eguchi; Taketoshi Matsumoto; Masahiko Shibuya; Yasufumi Yamaji; Yasuo Ohashi
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

2.  Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole.

Authors:  Hiroshi Yagata; Hiroshi Ohtsu; Yoshifumi Komoike; Shigehira Saji; Hiroyuki Takei; Toshitaka Nakamura; Yasuo Ohashi; Takuya Iwase; Kojiro Shimozuma
Journal:  Support Care Cancer       Date:  2015-07-08       Impact factor: 3.603

3.  Slovenian pharmacy performance: a patient-centred approach to patient satisfaction survey content development.

Authors:  Nejc Horvat; Mitja Kos
Journal:  Int J Clin Pharm       Date:  2011-10-08

4.  Validation of the care notebook for measuring physical, mental and life well-being of patients with cancer.

Authors:  Kunihiko Kobayashi; Joseph Green; Mari Shimonagayoshi; Noriaki Kanemoto; Ryo Kasai; Yoichi Itoh; Yuki Fujiki; Yasuo Ohashi; Carolyn Gotay; Shoji Kudoh
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

Review 5.  Quality of life in gastric cancer.

Authors:  Ad-A Kaptein; Satoshi Morita; Junichi Sakamoto
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

6.  Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial.

Authors:  Ryuichiro Doi; Masayuki Imamura; Ryo Hosotani; Toshihide Imaizumi; Takashi Hatori; Ken Takasaki; Akihiro Funakoshi; Hideyuki Wakasugi; Takehide Asano; Shoichi Hishinuma; Yoshiro Ogata; Makoto Sunamura; Koji Yamaguchi; Masao Tanaka; Sonshin Takao; Takashi Aikou; Koichi Hirata; Hiroyuki Maguchi; Koichi Aiura; Tatsuya Aoki; Akira Kakita; Makoto Sasaki; Masahiko Ozaki; Satoru Matsusue; Shunichi Higashide; Hideki Noda; Seiyo Ikeda; Shunzo Maetani; Shigeaki Yoshida
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

7.  Significance of age-associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan.

Authors:  Koji Takada; Shinichiro Kashiwagi; Yuka Asano; Wataru Goto; Tamami Morisaki; Katsuyuki Takahashi; Masatsune Shibutani; Ryosuke Amano; Tsutomu Takashima; Shuhei Tomita; Kosei Hirakawa; Masaichi Ohira
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

8.  Evaluation of quality of life and psychological response in cancer patients treated with radiotherapy.

Authors:  Takeo Takahashi; Mikito Hondo; Keiichiro Nishimura; Akira Kitani; Takafumi Yamano; Hisami Yanagita; Hisato Osada; Munefumi Shinbo; Norinari Honda
Journal:  Radiat Med       Date:  2008-09-04

9.  The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in japanese patients with advanced non-small-cell lung cancer.

Authors:  T Matsumoto; Y Ohashi; S Morita; K Kobayashi; M Shibuya; Y Yamaji; K Eguchi; M Fukuoka; K Nagao; Y Nishiwaki; H Niitani
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

10.  Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer.

Authors:  S Negoro; N Masuda; Y Takada; T Sugiura; S Kudoh; N Katakami; Y Ariyoshi; Y Ohashi; H Niitani; M Fukuoka
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.